13F HOLDINGS REPORT
Sarissa Capital Management LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000899140-25-000705
Total Value
$154.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INNOVIVA INC | INVA | 2,816,022 | $51.1M | 33.00% |
| 2 | NEUROCRINE BIOSCIENCES INC | NBIX | 309,116 | $34.2M | 22.10% |
| 3 | CYTOKINETICS INC | CYTK | 600,000 | $24.1M | 15.59% |
| 4 | IRONWOOD PHARMACEUTICALS INC | IRWD | 16,390,000 | $24.1M | 15.57% |
| 5 | AMARIN CORP PLC | AMRN | 24,850,623 | $11.1M | 7.20% |
| 6 | LANTHEUS HLDGS INC | LNTH | 100,000 | $9.8M | 6.31% |
| 7 | VOR BIOPHARMA INC | VOR | 508,016 | $364,501 | 0.24% |